Maverick Silicon led Lyte’s $165M Series C at a $1.6B post-money valuation — former Apple/PrimeSense engineers shipping synchronized vision silicon for physical AI, with Fidelity returning from the Series B.
Morgan Health led Thyme Care’s $125M+ Series E above a $2B valuation — Humana, CVS Health Ventures, AlleyCorp, and a16z Bio + Health joined as the company spins up Thyme Companies for biosimilars and trial access.
Wonderful announced a $550 million Series C on September 2, 2026. TechCrunch and the Wall Street Journal put the mark at $5 billion, 2.5× the March $2 billion Series B. Insight Partners led again. ARR was not disclosed. WSJ separately reported $170 million of employee-share purchases.
Wonderful’s $550 million Series C at a $5 billion press mark, Palo Alto Networks’ Console acquisition ($500 million is still reported), and iPronics’ $125 million Nvidia-participating Series B. Roundup-only: Metal $4.5 million, Cognition ~$47 billion reported, Moonshot HK IPO talks. Félix and Thyme Care/Lyte/HiddenLayer sit on other September indexes.
Valencia-based iPronics announced a $125 million Series B on September 2, 2026, co-led by Maverick Silicon and Light Street Capital, with Nvidia joining. Total funding is now $177 million. Valuation was not disclosed. The product is a silicon-photonics optical circuit switch for AI clusters, not a GPU.
Palo Alto Networks announced on September 1, 2026 that it has acquired Console, a Thrive- and DST-backed IT-agent startup. Terms were not in the press release. TechCrunch, citing two people, said $500 million in cash and stock versus a $157 million PitchBook last mark and $29 million raised.
